Plain-English translation of NCT06220656 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
The TRAIL Study is testing whether people with thyroid nodules that look suspicious on ultrasound can safely be monitored closely with regular ultrasound scans instead of having an immediate biopsy. Researchers want to see if active monitoring reduces anxiety and improves quality of life compared to getting biopsied right away, while still catching any cancer early if the nodule changes.
Many thyroid nodules that look concerning on ultrasound turn out not to be cancer, but people often have immediate biopsies anyway—which can cause anxiety and may lead to unnecessary surgery. This trial is exploring whether careful monitoring with ultrasound can be a safer, less stressful option for some patients while still protecting their health.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to either the immediate biopsy group (standard care) or the active monitoring group. If you are in the active monitoring group, you will have an ultrasound and meet with a clinician every six months for two years, then less often after that—allowing doctors to watch for any changes in your nodule. If you are in the immediate biopsy group, you will have a biopsy in the office, and depending on the results, you may need surgery or ongoing monitoring. Throughout the study, researchers will ask about your anxiety and quality of life.
AI-generated summary from trial data · Jun 10, 2026 · Not medical advice
United States